Lyn Boreland1, Marcia Scott-Hudson1, Kathy Hetherington1, Antoinette Frussinetty1, Jason T Slyer2. 1. Pace University, College of Health Professions, Lienhard School of Nursing, 163 William Street, 5th Floor, New York, NY 10038, USA. 2. Pace University, College of Health Professions, Lienhard School of Nursing, 163 William Street, 5th Floor, New York, NY 10038, USA. Electronic address: jslyer@pace.edu.
Abstract
OBJECTIVE: A systematic review of the effects of tight glycemic control with a continuous insulin infusion to achieve blood glucose levels ≤ 200 mg/dL on surgical site infections and readmission rates in adult patients with diabetes after cardiac surgery. METHODS: A quantitative systematic review of the literature. Databases, including PubMed, CINAHL, EMBASE, and CENTRAL, were searched for relevant studies from database inception through August 2014. Randomized and quasi-experimental studies were included. RESULTS: A meta-analysis of ten studies demonstrated that glycemic control with a continuous insulin infusion to achieve blood glucose levels ≤ 200 mg/dL significantly reduced surgical site infection rates (odds ratio 0.35, 95% confidence interval 0.25-0.49; Z = 6.0, P < 0.00001) compared with standard diabetes management. CONCLUSIONS: Maintaining blood glucose levels ≤ 200 mg/dL with a continuous insulin infusion in all stages of the perioperative period in cardiac surgery patients with diabetes can reduce the incidence of surgical site infections.
OBJECTIVE: A systematic review of the effects of tight glycemic control with a continuous insulin infusion to achieve blood glucose levels ≤ 200 mg/dL on surgical site infections and readmission rates in adult patients with diabetes after cardiac surgery. METHODS: A quantitative systematic review of the literature. Databases, including PubMed, CINAHL, EMBASE, and CENTRAL, were searched for relevant studies from database inception through August 2014. Randomized and quasi-experimental studies were included. RESULTS: A meta-analysis of ten studies demonstrated that glycemic control with a continuous insulin infusion to achieve blood glucose levels ≤ 200 mg/dL significantly reduced surgical site infection rates (odds ratio 0.35, 95% confidence interval 0.25-0.49; Z = 6.0, P < 0.00001) compared with standard diabetes management. CONCLUSIONS: Maintaining blood glucose levels ≤ 200 mg/dL with a continuous insulin infusion in all stages of the perioperative period in cardiac surgery patients with diabetes can reduce the incidence of surgical site infections.
Authors: Lily E Johnston; Jennifer L Kirby; Emily A Downs; Damien J LaPar; Ravi K Ghanta; Gorav Ailawadi; Benjamin D Kozower; Irving L Kron; Anthony L McCall; James M Isbell Journal: Ann Thorac Surg Date: 2016-08-25 Impact factor: 4.330
Authors: Dorin T Colibaseanu; Osayande Osagiede; Rozalina G McCoy; Aaron C Spaulding; Elizabeth B Habermann; James M Naessens; Michelle F Perry; Launia J White; Robert R Cima Journal: Endocr Pract Date: 2018-10-05 Impact factor: 3.443
Authors: Stephanie Ostling; Jennifer Wyckoff; Scott L Ciarkowski; Chih-Wen Pai; Hae Mi Choe; Vinita Bahl; Roma Gianchandani Journal: Clin Diabetes Endocrinol Date: 2017-03-22